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Abstract 
Background. Governmental organizations are facing challenges in adjusting procedures providing equitable 
assistance to consumers with amputation choosing newly available osseointegrated fixations for bone-anchored 
prostheses over socket-suspended prostheses.  
Objectives. The objectives were (1) to present a procedure focusing on tasks, documents and costs of prosthetic 
care, and (2) to share observed obstacles and facilitators to implementation.  
Methods. This research aiming at developing a governmental procedure for the provision of bone-anchored 
prostheses was designed as an action-research study. A total of 18 individuals with transfemoral amputation solely 
funded by a Queensland State organization were considered.  
Results. The procedure developed between 01/2011 and 06/2015 included seven processes involving fixed expenses 
during the treatment and five processes regulating ongoing prosthetic care expenses. Prosthetic care required 22 
hours of labor corresponding to AUD$3,300 per patient during rehabilitation. Prosthetists spend 64% and 36% of 
their time focusing on prosthetic care and other activities, respectively. The procedure required adjustments related 
to scope of practice of prosthetists, funding of prosthetic limbs during rehabilitation and allocation of 
microprocessor-controlled prosthetic knees. Approximately 41% (7) and 59% (10) of the obstacles were within 
(e.g., streamlining systematic processes, sustaining evaluation of this complex procedure) or outside (e.g., early and 
consistent consultations of stakeholders, lack of a definitive rehabilitation program) governmental control, 
respectively. Approximately, 89% (17) of the facilitators were within governmental control (e.g., adapting existing 
processes).  
Conclusion. This study provides a working plan to stakeholders developing and implementing policies around care 
of individuals choosing osseointegration for bone-anchored prostheses. 
 
 
Key Points for Decision Makers 
 The demand from prosthetic care providers and policy-makers for an in-depth presentation on an 
implementable procedure for the provision of bone-anchored prostheses is yet to be addressed. 
 A procedure for provision of bone-anchored prostheses could include seven processes involving fixed 
expenses during the treatment and five processes regulating ongoing prosthetic care expenses.  
 A total of 22 hours of prosthetist’s labor, corresponding to $3,300 was deemed sufficient to provide a 
bone-anchored prosthesis to an individual with a transfemoral amputation during the rehabilitation 
program. 
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1. ABBREVIATIONS  
APN: Assessment of Prosthetic Needs 
BAP: Bone-anchored prosthesis 
CPC: Clinical Prosthetic Clearance 
PID: Prosthetic Issue Document 
PSP: Prosthetic Service Provider 
QALS: Queensland Artificial Limb Service 
 
2. INTRODUCTION  
2.1.  Background 
Current and projected numbers of amputations 
are alarming. In the US alone, Ziegler-Graham et al 
(2008) indicated that “One in 190 Americans is 
currently living with the loss of a limb. Unchecked, 
this number may double by the year 2050”.[1]p422 
Some individuals suffering with lower limb 
amputation might be non-prosthetic users due to 
residuum issues (e.g., short residual bone, pain, skin 
and soft tissue damage).
[2]
 Others will try to use a 
prosthesis reliant on a socket enveloping their 
residuum. Unfortunately, the regular manufacturing 
cost of custom-made sockets is expensive and could 
range from US$6,203 up to US$20,070 over the first 
five years following primary amputation.
[3, 4]
 
Furthermore, these prosthetic users will experience 
continuous socket-related discomfort. All tend to 
experience a dramatic decrease in quality of life.
[5]
  
It is becoming apparent that most of these 
functional issues can be overcome by replacing the 
socket with a surgically implanted bone-anchored 
prosthesis (BAP) attached directly to the residual 
bone using an osseointegrated fixation.
[6-14]
 Few 
commercial fixations have been trialed and 
monitored over the last decade.
[4, 15-17]
 Several other 
fixations are currently in various stages of 
development in Europe and the US, leading to recent 
Food and Drug Administration approvals.  
BAP engenders major clinical benefits (e.g.,  
prosthetic use, body image, hip range of motion, 
sitting comfort, ease of donning and doffing, 
osseoperception, walking ability, sustained extended 
daily activities) with acceptable clinical risks (e.g., 
implant stability, rate of infection, effect of a fall, 
breakage of fixation parts) leading to a significant 
improvement in health-related quality of life, 
particularly for young, active and non-vascular 
individuals with transfemoral amputation.
[13, 15-34]
 
Authors often indicated that BAP could potentially 
reduce some prosthetic, medical and financial burden 
for health service administrators by reducing the 
treatment of skin-socket interface problems over the 
consumer’s lifespan. Indeed, Haggstrom et al (2012) 
reported that patients with BAP “make significantly 
fewer visits per year to a prosthetic workshop 
compared with a similar group using [socket] 
prostheses. Despite the differences in visits for 
prosthetic service between the groups the overall 
prosthetic costs for [BAP] prostheses were 
comparable with those for [socket] prostheses. We 
suggest this is due to more sophisticated components 
that can be used with [BAP]”.[35] p159 
Consequently, governmental organizations are 
now facing a range of challenges in adjusting their 
procedures to include fair and equitable financial 
assistance for consumers choosing BAP.
[36]
 Formal 
documentation about procedures for the provision of 
prosthetic services set by funding organizations 
supporting BAP consumers is sparse.
[37-43]
 Some 
summary elements of an Australian state’s 
procedures have been presented but only in abstract 
form.
[44, 45]
  
Altogether, there is insufficient information to 
implement a pre-established procedure for prosthetic 
service provision. The demand from prosthetic care 
providers and policy-makers for an in-depth 
presentation of an implementable procedure is yet to 
be addressed.
[46]
  
 
2.2.  Objectives 
The objectives of this study were:  
1. To present a procedure implemented by an 
Australian State organization, with an 
emphasis on lists of tasks and documents, as 
well as cost required to support prosthetic 
care at each stage of treatment with BAP, 
2. To share some initial and ongoing obstacles 
as well as known and suggested facilitators 
to implementation to be drawn from this 
experience. 
 
3. METHODS 
3.1.  Study design  
This primary research aiming at developing a 
governmental procedure for the provision of BAP 
was designed as an action-research study following 
guidelines for data-driven collaboration and 
interactive inquiry process. 
[47]
 
The procedure was developed over one action-
research cycle that started in January 2011, 
approximately six months before the first consumer 
was treated in Queensland. The timeline and key 
actions for interconnected planning, doing, studying 
and acting steps of this development are detailed in 
Figure 1. The planning step consisted on creating an 
initial ad hoc procedure combining information from 
clinical literature and assessment of current 
Queensland Artificial Limb Service (QALS) 
procedure during first 6 months. The doing step 
corresponded to the trialling of the ad hoc procedure 
during 18 months while monitoring treatment 
pathways, contribution of each team member and 
supporting documentation. The studying step 
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involved analyzing the trialling phase for 6 months 
using interviews with stakeholders to identify 
shortcomings and, ultimately, generate the formal 
procedure. The first 30 months for the three first 
steps were essential to develop a prosthetic care-
focused procedure at each key stage of the treatment 
for BAP. Finally, the acting step involved 
implementation of the formal procedure for over 24 
months. Stakeholders were informed of new 
processes and documents, while creating evaluation 
mechanisms to monitor procedure performances over 
time (e.g., compliance to procedure, consumer, 
satisfaction, individual and overall costs) for 
evidence-based analysis during next action-research 
cycle of procedure’s revision. The acting step 
concluded with a collective consensus-based 
reflection aiming at identifying obstacles and 
facilitators to implementation to be drawn from this 
experience. 
 
* Figure 1 * 
 
3.2.  Setting 
This study was undertaken by the Queensland 
Artificial Limb Service from the State of 
Queensland, Australia (Table 1).  
In essence, QALS’ role is to ensure an equitable 
provision and funding of external prosthetic 
components to eligible residents of Queensland, 
including those opting for BAP. Eligible consumers 
must be registered with QALS and (A) be eligible for 
definitive prosthetic funding support under the 
Queensland Government’s ‘Artificial Limb Scheme’, 
or (B) be eligible under the Rehabilitation Appliance 
Program of the Department of Veteran Affairs.   
QALS was particularly prompted to develop a 
procedure because it is currently facing one the 
strongest influx of consumers opting for BAP as 
Queensland’s tropical heat and humidity make 
socket-prostheses challenging to wear. Additional 
drives to develop the procedure including benefits of 
BAP, economic incentives and managerial decision 
are provided in Table 1. 
 
* Table 1 * 
 
The development of the procedure was led by a 
committee set by QALS including: the QALS 
management team; researchers in health economics; 
the five first consumers; three Prosthetists referred to 
as Prosthetic Service Provider (PSP) working in 
private settings; two clinical teams involved in the 
surgical implantation of osseointegrated fixations and 
the rehabilitation with BAP. 
[48, 49]
 
 
3.3.  Participants 
This study involved all the Queensland-based 
consumers with transfemoral amputation treated with 
BAP across Australia between 01/2011 and 06/2015. 
The only eligibility criterion was to be registered by 
QALS according to the requirements presented 
above. Inclusion criterion was that participants must 
be solely funded by QALS without contribution from 
other associated organizations. Consequently, 
consumers jointly funded under the Rehabilitation 
Appliance Program of the Department of Veteran 
Affairs were excluded as they might experience 
different benefits.   
 
3.4.  Variables 
Several variables were considered during the 
trial and analysis steps of the development of the 
procedure (Figure 1) helping QALS to determine a 
list of relevant tasks and documents enabling 
prosthetic care at each of the five stages of the BAP 
treatment (i.e., Pre-op, surgeries, post-op, light limb, 
definitive limb, ongoing prosthetic care).  
Qualitative variables were used to describe the 
formal procedure allowing the description of what 
type of actions (e.g., Consult, report, assess, fit) must 
be undertaken by which specialists (e.g., whole team, 
PSP, orthopedic surgeons, rehabilitation physicians) 
at what stage of the treatment.  
Quantitative variables were used to characterize 
fixed costs for PSPs’ contribution including the 
frequency and duration of intervention of PSPs labor 
at set hourly fee of $150 to provide prosthetic 
services and components to consumers.
[50]
 All costs 
are reported in Australian dollars (1 Australian dollar 
≈ 0.71 Euro ≈ 0.60 British pound ≈ 0.76 US dollar) 
according to 2016-17 prices. 
Additional qualitative variables were also 
considered to establish the list: initial and ongoing 
obstacles as well as known and suggested facilitators 
that were either within or outside governmental 
control using stepwise process leading to consensus 
including: discussion, initial identification and 
collaborative modification until final agreement with 
the lists. 
 
3.5.  Data sources 
QALS developed the procedure after monitoring 
literature focusing on dissemination and 
implementation of procedures using various model’s 
construct (e.g., Conceptual Model of Implementation 
Research, Implementation Effectiveness Model, 
PARIHS) and clinical developments of BAP, 
particularly the rehabilitation, worldwide and in 
Australia over a decade. 
[51-55]
 
The development of the procedure relied on 
review of QALS’s formal documentation for current 
procedure for provision of typical socket prostheses, 
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specifically the “Schedule of Allowable Hours” and 
“Schedule of Repairs to Prosthesis”.  
 
4. RESULTS 
4.1.  Participants 
A total of 18 individuals living in Queensland 
were treated during this study. A total of 16 
participants solely funded by QALS were considered 
while two were discarded as they were covered by 
Department of Veteran Affairs.  
 
4.2.  Descriptive data 
The cohort included five (31%) females and 11 
(69%) males altogether with an average, standard 
deviation and age range of 53±10 [38, 67] years, 
height of 1.73±0.12 [1.51, 1.92] m, mass of 80±20 
[51,120] kg, distance between residence and closest 
point of prosthetic care of 184±164 [8, 506] km and 
distance between residence and Brisbane capital city 
of Queensland of 247±331 [9, 1,335] km, 
respectively. Ten, two and four individuals were 
amputated due to trauma, tumor or other causes, 
respectively.  The lapse since initial amputation and 
the beginning of the study was 23±13 [1, 48] years. 
 
4.3.  Outcomes data 
4.3.1. Description of procedure 
A dynamic overview QALS’ formal procedure 
for provision of BAP as implemented during acting 
step is presented in Figure 2 detailing the 
intersections between the treatment stages, tasks, 
specialists, documents and actions involved in 12 
processes during five sequential phases of procedure. 
As detailed in Task sections of Figure 2, the 
series of actions forming the formal procedure 
include seven processes involving fixed expenses 
during the course of the BAP treatment. The 
remaining five processes regulate ongoing expenses 
for long-term prosthetic care.   
Phase 1 (P1) occurs six months pre-operatively. 
QALS reimburses PSPs for consultation during the 
screening of consumers (e.g., inclusion and exclusion 
clinical criteria) and for creation of an individual 
“passport of service” to record clinical and prosthetic 
milestones (e.g., patient journey). QALS does not 
provide funding for surgical costs. 
Phase 2 (P2) occurs between surgeries and post-
operative stages and lasts approximately two months. 
QALS reimburses PSPs for a consultation before 
consumers start the rehabilitation program, 
establishing base line prosthetic assessment and 
completing the passport. QALS does not provide 
funding associated with inpatient rehabilitation care.   
Phase 3 (P3) occurs approximately six months 
after the surgery. It involves fitting light prosthesis 
during the first part of rehabilitation program.
[56, 57]
 
Orthopedic Specialists complete and email to QALS 
the first Clinical Prosthetic Clearance (CPC) form, 
indicating that consumers are ready to progress onto 
rehabilitation with a light prosthesis. This temporary 
prosthesis required to complete the osseointegration 
is built with basic components. PSPs are encouraged 
to use consumer’s pre-existing prosthetic components 
when possible. PSPs list the components required 
with justification on an Assessment for Prosthetic 
Needs (APN) form and submit to QALS for funding 
approval. PSPs are responsible for evaluating, 
designing, manufacturing and fitting the light 
prosthesis. QALS reimburses PSPs based on the 
approved APN form, completion of the Prosthetic 
Issue Document (PID) form and updating of the 
passport. 
Phase 4 (P4) occurs during the last six months 
upon completion of the rehabilitation program with 
the light prosthesis. It involves assessing and fitting 
the definitive prosthesis. PSPs consult with 
Rehabilitation Specialists to complete a second CPC 
form. Physiotherapists conduct a mobility assessment 
using standard instrument (i.e., Amputee Mobility 
Predictor Assessment Tool). The prosthetic 
assessment is also based on PSP’s expert judgment 
considering a range of consumers’ circumstances 
including, but not limited to, lifestyle needs, work 
commitments, social interactions and home 
environments. PSPs are also encouraged to consider 
consumers’ pre-existing components. QALS 
recommends that a basic definitive limb must include 
a connector, protective device, an economical 
microprocessor-controlled knee and a foot with 
torque absorber, to ensure safe ambulation (e.g., fall, 
protective loading profile) during activities of daily 
living.
[20, 21, 31, 32, 58-61]
 Only Therapeutic Goods 
Administration certified and QALS registered 
components are considered acceptable. PSPs include 
the final list of components and justification on an 
APN form to be approved for funding by QALS and 
instruct consumers on basic component care and 
must advise them of their prosthesis’ loading and 
activity limitations (e.g., water conditions, physical 
activities, environment, fall safety). Finally, QALS 
reimburses PSPs to assess, design, manufacture, fit 
and adjust the definitive prosthesis. A PID is 
completed when the definitive prosthesis is trialled 
and the passport is updated with treatment and 
services provided. Furthermore, consumers are asked 
to complete the acquittal and quality assurance 
survey upon acceptance of their definitive prosthesis. 
Phase 5 (P5) involves long-term ongoing 
prosthetic care after initial fitting of the definitive 
prosthesis. PSPs are responsible for evaluating, 
fitting and reporting all activities related to services 
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and repairs of definitive prostheses. Consumers’ 
prosthetic needs can be re-assessed if needed using 
the process presented above. Fitting of new 
components must follow the conditions of use and 
government guideline (e.g., components 
manufacturing warranties, periods of use). PSPs are 
responsible for completing the passport when 
changes are conducted.   
The performance of the procedure is evaluated 
using the standard QALS’ Prosthetic Service 
Evaluation Form (e.g., QALS Form P009) and 
monitoring of verbal and written feedback sent to 
QALS Consumer Advisory Committee as well as 
reporting individual and overall costs for BAP.  
 
* Figure 2 * 
 
4.3.2.  Cost of PSP involvements 
The breakdown of frequency and duration of 
intervention of PSPs labour included at the heart of 
formal QALS’ procedure is provided in Table 2. The 
studying step of action research (Figure 1) led to an 
agreement between stakeholders that a total of 22 
hours of labor corresponding to $3,300 were 
sufficient to accommodate both PSPs’ prosthetic care 
standards and QALS’ financial resources. PSP labor 
allocated to P1, P2, P3 and P4 included 2.5, 2.5, 6.5 
and 10.5 hours corresponding to 11 ($375), 11 
($375), 30 ($975) and 48 ($1,575) percent of the total 
labor cost, respectively. PSPs could spend up to 4, 2, 
14 and 2 hours for consultation, evaluation, fitting 
and reporting activities corresponding to 18 ($600), 9 
($300), 64 ($2,100) and 9 ($300) percent of the total 
labor cost, respectively. As expected, PSPs spend the 
vast majority of the time (64%) focusing on 
prosthetic care only (e.g., fitting, alignment). 
Nonetheless, they also spend some significant effort 
(36%) to conduct other, perhaps more clinical and 
managerial, underlying activities. PSPs were 
logically involved in provision of definitive limbs 
and subsequent ongoing long-term prosthetic care 
(P5) upon completion of rehabilitation applying 
typical QALS’ procedures. 
 
* Table 2 * 
 
4.3.3.  Obstacles and facilitators 
The list of obstacles and facilitators identified 
during the last part of the acting step are provided in 
Table 3 and Table 4, respectively.  A total of 17 
obstacles were collectively identified including nine 
initial and eight ongoing ones. A total of 41% (7) and 
59% (10) were within and outside governmental 
control. A total of 19 facilitators were collectively 
identified including ten known and nine suggested 
ones. Approximately 89% (17) and 11% (2) were 
within and outside governmental control.  Critical 
obstacles and facilitators are further developed in the 
Discussion section.  
  
* Table 3 and Table 4 * 
 
5. DISCUSSION 
5.1.  Key results 
This study showed that: 
 The procedure developed between 
01/2011 and 06/2015 included seven 
processes involving fixed expenses 
during the treatment and five processes 
regulating ongoing prosthetic care 
expenses.  
 Prosthetic care required 22 hours of 
labor corresponding to $3,300 per 
patient during rehabilitation. 
Prosthetists spend 64% and 36% of 
their time focusing on prosthetic care 
and other underlying activities, 
respectively.  
 Stepwise process identified a list of 
initial and ongoing obstacles as well as 
known and suggested facilitators that 
were deemed within and outside the 
governmental control.  
 
5.2. Interpretations 
5.2.1. Adjustments  
  The proposed procedure was largely 
inherited from previous procedures for conventional 
prostheses that are more likely to be used by most 
governmental organizations. However, significant 
adjustments were made to accommodate specific 
BAP prosthetic care. 
The first adjustment related to the involvement 
of qualified prosthetists. At this stage, PSPs’ scope of 
practice and activities were compliant with 
Australian competency standards for qualified 
prosthetists.
[62]
 However, it is anticipated that 
prosthetists might become the “gate keeper” for 
patients with BAP, which could possibly put them in 
a more predominant case manager role. They will 
remain primarily in charge of regular and incidental 
prosthetic care (e.g., maintenance, adjustments, 
loading profile management, breakage of fixation 
part after fall). In addition, they will be more likely to 
become the first point of care to prevent, diagnose 
and refer for treatment at initial signs of infections, 
for example.   
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Another adjustment was the funding of light 
limb during rehabilitation. Typically, governmental 
organizations provide essentially definitive 
prostheses. However, the success of treatment relies 
on progressive loading for strong bonding between 
bone and fixation called osseointegration. This 
requires the use of a light limb during rehabilitation 
program corresponding to the Stage 3 of the 
procedure. Built with basic components this 
temporary prosthesis only provides limited range of 
movement and restricted ambulation. Attempt to 
minimize costs were made by encouraging PSPs to 
use of patient’s own pre-existing components when 
possible without compromising safety (e.g., single 
axis knees, pylon, feet).   
The last significant adjustment involved the 
allocation of advanced microprocessor-controlled 
knees providing critical biomechanical advantages 
but costing up to $60,000 per unit. This might be 
beyond the typical standard funding guidelines for 
most governmental organizations, even for the most 
functional consumers with very active lifestyles. 
Review of standards for allocation of prosthetic knee 
units was needed since consumers with BAP must be 
fitted with microprocessor-controlled knees mainly 
for safety reasons (e.g., loading profile, fall 
prevention).
[20, 21, 31, 32, 58-61]
 Fortunately, this 
adjustment was eased by agreements with prosthetic 
suppliers to provide QALS consumers with an 
affordable component package for under $20,000, 
including appropriate knee and foot units.    
  
5.2.2. Manageable obstacles 
The acting step revealed that the current 
number of processes remains on obstacle within the 
governmental control to overcome. As presented in 
Figure 2, the existing procedure relies essentially on 
PSPs to coordinate and document up to 12 processes 
per consumer during the first year. The underlying 
paper work is time-consuming and burdensome. 
Therefore, efforts could be made to streamline 
systematic processes around provision of expensive 
items (e.g., light and definitive limbs) while insuring 
responsibility of clinical stakeholders, quality and 
control over expenses.    
As identified during the planning step, an 
initial obstacle outside governmental control was the 
lack of a definitive rehabilitation program, 
particularly for the treatment with press-fit fixation 
for transfemoral amputations. This issue is resolving 
as particular rehabilitation programs for this case-mix 
are becoming more established. 
[8-11, 13, 16, 63-67]
 
Nonetheless, this has led to uncertainty in the 
relevance and timing of PSP involvement for pre-
operative, surgery and post-operative prosthetic care. 
Unfortunately, a lack of specific rehabilitation 
programs is likely to remain ongoing and demand 
consistent attention in upcoming years with 
anticipated emergence of new fixations. These 
treatments might involve rehabilitation programs 
different from those currently available and, 
consequently, require different PSPs involvements.  
Sustaining and evaluating this complex 
procedure are some of the main ongoing challenges 
partially under the control of governmental 
organization due to continual BAP clinical 
improvements (e.g., surgical procedures, long terms 
outcomes) and development of prosthetic 
components (e.g., biomechanical performance, cost). 
 
5.2.3. Transferable facilitators 
The experience reported here revealed 
several key facilitators for implementation that are 
transferable to other settings including, but not 
limited to: 
 Early and consistent consultations of 
stakeholders to warrant appropriateness of 
the intervention and process compliance of 
consumers, prosthetists and clinicians (e.g., 
orthopedic surgeons, physiotherapists),  
 Adapting existing processes rather than 
creating new ones while taking into 
consideration involvement of PSPs, fitting 
of light limb during rehabilitation and need 
for microprocessor-controlled knees units, 
 Use a document to track patient’s journey 
(e.g., passport of service) to contribute to 
patient empowerment and to facilitate 
continuum of care particularly for 
multidisciplinary services performed 
interstate, 
 Establishing systematic processes focusing 
on assessment, approval before 
reimbursement, provision and reporting of 
expensive items.
[68]
 
 
5.3.  Limitations 
The procedure has been implemented over two 
years for 18 consumers. All participants had 
unilateral transfemoral amputation. They were 
mainly located in metropolitan areas in reasonable 
proximity of PSPs. Only a small number of dedicated 
PSPs and clinicians were involved. 
  
5.4.  Generalization 
The overall two-year duration of observation 
allowed us considering a convenient cohort size of 16 
participants. This number might be considered 
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sufficient given the limited number of patients 
accessing this type of treatment (e.g., eligibility, out-
of-pocket costs). This sample size is slightly above 
the average of 14 participants in studies in the field 
of prosthetics.
[69]
 Furthermore, the population could 
be possibly representative as it corresponded to 13% 
and 3.2% of existing population estimated at 120 in 
Australia and 500 worldwide, respectively.  
On the other hand, only a narrow case-mix 
limited to individuals with transfemoral amputation 
was considered. Also, only one action research cycle 
was conducted.   
Finally, one additional limitation to 
generalisation is that this procedure was only a 
reflection of an Australian State organisation 
focusing on prosthetic care. Treatment pathways for 
provision of BAP could differ between jurisdictions. 
For example, costs for BAP fall mainly under the rim 
of rehabilitation providers and not PSPs only in some 
European countries. In the US, active duty members 
treated through a Department of Defence research 
protocol supported by Food and Drug Administration 
approved Humanitarian Device Exemptions may 
apply for a waiver under the Supplemental Health 
Care Program process.  
Altogether, one can argue that generalization of 
these study outcomes must be considered carefully. 
Furthermore, the potential for scalability of this 
procedure within and between jurisdictions also 
remains to be confirmed more particularly its 
capacity to integrate more complex case mixes (e.g., 
transtibial, multi-level amputations), the geographical 
spread of consumers extending to rural areas with 
limited access to a PSP, the increasing number of 
treatment sites in Australia and abroad as the surgery 
becomes more routinely performed.    
 
5.5.  Future studies 
Clearly, there will be a need to further extend 
this procedure to accommodate future developments 
in BAP including, but not limited to, growing 
number of consumers, broadening of case mix, 
changes to surgical procedures, emergence of 
multiple treatment centers, constant developments of 
prosthetic components.
[59, 70-73]
 Effects of these 
changes in the development, implementation and 
evaluation of QALS’ procedure could be achieved 
through a range of subsequent studies.  
Further longitudinal studies will focus on 
systematic evaluation of stakeholders’ compliance 
and satisfaction with the procedure including 
primarily consumers and PSPs over an extended 
period of time (e.g., six-year funding cycle).
[74]
 
Satisfaction of PSPs will be of particular interest as 
the BAP could possibly lead to loss of income due to 
reduction of socket manufacturing. Consequently, a 
cross-comparison of compensation provided by 
QALS ($3,300) will be needed to establish whether 
BAP represents a loss, comparable or increased 
revenues for PSPs. 
Additional cross-sectional studies will focus on 
procedure performances in combination with 
measure of impact of BAP on physical functioning 
(e.g., level of activities of daily living), health related 
quality of life (e.g., physical and mental 
components), employment (e.g., return to work, 
reduction of sick leave) and cost-effectiveness of 
BAP compared to socket prostheses (e.g., re-use of 
pre-existing components, cost-comparison, cost per 
quality adjusted life year, incremental cost-
effectiveness ratio) and other orthopedic device (e.g., 
knee and hip implants).
[5, 15, 17, 18, 20, 21, 30, 32, 35, 75-79]
 
Altogether, this new information will facilitate 
product development and effective adoption of 
procedure for a sustainable provision of BAP. 
[48, 80]
 
 
6. CONCLUSIONS 
For the first time an overview of how a 
procedure from one governmental organization could 
provide bone-anchored prostheses is presented. The 
experience reported here is a stepping-stone 
providing a working plan for both development and 
implementation of procedure to stakeholders 
responsible for policies around care of individuals 
fitted with bone-anchored prostheses.  
 
7. ACKNOWLEDGMENT  
The authors wish to express their gratitude to Dr 
Richard Ashby and John Vasil for their contribution 
to the development of this project, Dr Munjed Al 
Muderis, Dr Aditya Khemka and Belinda Bosley for 
their insight into clinical care, Fiona Barnett, Stephan 
Laux, Barry Leech and Luke Lorenzin for their 
insight into prosthetic care. 
 
8. COMPLIANCE WITH ETHICAL 
STANDARDS  
 The study followed ethical guidelines from the 
Queensland Health’s Health Innovation, 
Investment and Research Office (HIIRO) 
responsible for consultation, development and 
review of State-wide research ethics and 
research governance policies. 
 The University of the Sunshine Coast received 
funding from QALS to conduct the study. 
 Laurent Frossard, Adjunct Professor at the 
University of the Sunshine Coast and Director of 
YourResearchProject Pty Ltd was appointed as 
consultant by the University of the Sunshine 
 Development of a procedure for the government provision of bone-anchored prosthesis using 
osseointegration in Australia 
2017, PharmacoEconomics Open - http://rdcu.be/s99d2017 Page 8 of 18 
 
Coast to manage this project of research 
including collection, analysis and reporting 
procedure and cost data. 
 Laurent Frossard, Director of 
YourResearchProject Pty Ltd has work as 
consultant for several organisations on non-
related educational programs and projects of 
research to work recording of loading data, 
development of database to record clinical 
outcomes as well as drafting of grants and 
manuscripts. 
 Gregory Merlo declares that he has no conflict of 
interest. 
 Tanya Quincey is a client service officer at 
QALS and receives a salary from Metro-South 
Hospital and Health Service, Queensland Health. 
 Brendan Burkett is a Professor at the University 
of the Sunshine Coast and managed the funding 
provided by QALS and receives a salary from 
the University of the Sunshine Coast. 
 Brendan Burkett was also the first Australian 
with transfemoral amputation fitted with Integral 
Leg Prosthesis (Orthodynamics, UK) fixation.  
 Debra Berg is the Manager of QALS and 
receives a salary from Metro-South Hospital and 
Health Service, Queensland Health. 
 
 
9. DATA AVAILABILITY STATEMENT  
 All data generated or analysed during this study 
are included in this published article.  
 The QALS procedure for provision bone-
anchored prostheses to Queensland consumer 
generated during during the current study is 
available from the corresponding author on 
reasonable request. 
 Generic information about QALS procedures is 
available at: https://www.health.qld.gov.au/qals  
 
 
10. AUTHOR CONTRIBUTIONS 
 Laurent Frossard has contributed to the 
management of the whole study including design 
of methods, collect of information, analysis and 
interpretation of data and writing of manuscript.  
 Gregory Merlo has contributed to development 
of the methods, analysis and interpretation of 
data and writing of the manuscript.  
 Tanya Quincey had contributed to collect of 
information and review of manuscript. 
 Brendan Burkett has contributed to management 
of the project, interpretation of data and review 
of manuscript.  
 Debra Berg has contributed to management of 
the project, collect of information, interpretation 
of data and writing of manuscript. 
 
11. TO KNOW MORE 
  
 
 
12. REFERENCES 
1. Ziegler-Graham K, MacKenzie EJ, Ephraim PL, 
Travison TG, Brookmeyer R. Estimating the 
prevalence of limb loss in the United States: 
2005 to 2050. Arch Phys Med Rehabil. 
2008;89(3):422-9. 
doi:10.1016/j.apmr.2007.11.005. 
2. Raichle KA, Hanley MA, Molton I, Kadel NJ, 
Campbell K, Phelps E et al. Prosthesis use in 
persons with lower- and upper-limb 
amputation. J Rehabil Res Dev. 
2008;45(7):961-72.  
3. Smith DG, Horn P, Malchow D, Boone DA, 
Reiber GE, Hansen ST, Jr. Prosthetic history, 
prosthetic charges, and functional outcome of 
the isolated, traumatic below-knee amputee. J 
Trauma. 1995;38(1):44-7.  
4. Juhnke D, Beck J, Jeyapalina S, Aschoff H. 
Fifteen years of experience with Integral-Leg-
Prosthesis: Cohort study of artificial limb 
attachment system. J Rehabil Res Dev. 
2015;52(4):407-20. 
doi:10.1682/jrrd.2014.11.0280. 
5. Hagberg K, Brånemark R. Consequences of non‐
vascular trans‐femoral amputation: A survey 
of quality of life, prosthetic use and problems. 
Prosthet Orthot Int. 2001;25(3):186-94. 
doi:10.1080/03093640108726601. 
6. Hagberg K, Brånemark R. One hundred patients 
treated with osseointegrated transfemoral 
amputation prostheses - the rehabilitation 
perspective. Journal of Rehabilitation 
Research & Development. 2009;43(3):331-44.  
7. Branemark R, Berlin O, Hagberg K, Bergh P, 
Gunterberg B, Rydevik B. A novel 
osseointegrated percutaneous prosthetic 
system for the treatment of patients with 
transfemoral amputation: A prospective study 
of 51 patients. Bone Joint J. 2014;96(1):106-
13. doi:10.1302/0301-620X.96B1.31905. 
 Development of a procedure for the government provision of bone-anchored prosthesis using 
osseointegration in Australia 
2017, PharmacoEconomics Open - http://rdcu.be/s99d2017 Page 9 of 18 
 
8. Hillock R, Keggi J, Kennon R, McPherson E, 
Clyburn T, Brazil D et al. Stage II 
Osteointegration Implant (OI) Skin Coupling 
Procedure. Reconstructive review - Joint 
Implant Surgery & Research Foundation. 
2013;3(4):62-6.  
9. Hillock R, Tatum D, E D. Osseointegration 
Implant Post Coupling With External 
Prosthetic Limb Continuation of Previous 
Case Reports “Stage III”. Reconstructive 
review - Joint Implant Surgery & Research 
Foundation. 2014;4(2):13-6.  
10. Hillock R, Keggi J, Kennon R, McPherson E, 
Clyburn T, Brazil D et al. A Global 
Collaboration - Osteointegration Implant (OI) 
for Transfemoral Amputation - Case Report. 
Reconstructive review - Joint Implant Surgery 
& Research Foundation. 2013;3(2):50-4.  
11. Aschoff H-H, McGough R. The Endo-Exo 
Femoral Prosthesis: a new rehabilitation 
concept following above knee amputation. J 
Bone Jt Surg (Br). 2012;94-B(SUPP 
XXXIX):77.  
12. Branemark R, Branemark PI, Rydevik B, Myers 
RR. Osseointegration in skeletal 
reconstruction and rehabilitation: a review. J 
Rehabil Res Dev. 2001;38(2):175-81.  
13. Van de Meent H, Hopman MT, Frolke JP. 
Walking ability and quality of life in subjects 
with transfemoral amputation: a comparison 
of osseointegration with socket prostheses. 
Arch Phys Med Rehabil. 2013;94(11):2174-8. 
doi:10.1016/j.apmr.2013.05.020. 
14. Lundberg M, Hagberg K, Bullington J. My 
prosthesis as a part of me: a qualitative 
analysis of living with an osseointegrated 
prosthetic limb. Prosthet Orthot Int. 
2011;35(2):207-14. 
doi:10.1177/0309364611409795. 
15. Hagberg K, Branemark R, Gunterberg B, 
Rydevik B. Osseointegrated trans-femoral 
amputation prostheses: Prospective results of 
general and condition-specific quality of life 
in 18 patients at 2-year follow-up. Prosthet 
Orthot Int. 2008;32(1):29-41. 
doi:10.1080/03093640701553922. 
16. Hagberg K, Branemark R. One hundred patients 
treated with osseointegrated transfemoral 
amputation prostheses-rehabilitation 
perspective. J Rehabil Res Dev. 
2009;46(3):331-44.  
17. Hagberg K, Hansson E, Branemark R. Outcome 
of Percutaneous Osseointegrated Prostheses 
for Patients With Unilateral Transfemoral 
Amputation at Two-Year Follow-Up. Arch 
Phys Med Rehabil. 2014;95(11):2120-7. 
doi:10.1016/j.apmr.2014.07.009. 
18. Hagberg K, Haggstrom E, Uden M, Branemark 
R. Socket versus bone-anchored trans-femoral 
prostheses: hip range of motion and sitting 
comfort. Prosthet Orthot Int. 2005;29(2):153-
63.  
19. Frossard L, Stevenson N, Smeathers J, Lee Gow 
D, Gray S, Sullivan J et al. Daily activities of 
a transfemoral amputee fitted with 
osseointegrated fixation: continuous recording 
of the loading for an evidence-based practice. 
Kinesitherapie Revue. 2006;6(56-57):53-62.  
20. Lee W, Frossard L, Hagberg K, Haggstrom E, 
Brånemark R. Kinetics analysis of 
transfemoral amputees fitted with 
osseointegrated fixation performing common 
activities of daily living. Clin Biomech. 
2007;22(6):665-73.  
21. Frossard L, Stevenson N, Smeathers J, 
Haggstrom E, Hagberg K, Sullivan J et al. 
Monitoring of the load regime applied on the 
osseointegrated fixation of a trans-femoral 
amputee: a tool for evidence-based practice. 
Prosthet Orthot Int. 2008;32(1):68-78. 
doi:10.1080/03093640701676319. 
22. Nebergall A, Bragdon C, Antonellis A, Karrholm 
J, Branemark R, Malchau H. Stable fixation of 
an osseointegated implant system for above-
the-knee amputees: titel RSA and 
radiographic evaluation of migration and bone 
remodeling in 55 cases. Acta Orthop. 
2012;83(2):121-8. 
doi:10.3109/17453674.2012.678799. 
23. Haggstrom E, Hagberg K, Rydevik B, Branemark 
R. Vibrotactile evaluation: osseointegrated 
versus socket-suspended transfemoral 
prostheses. J Rehabil Res Dev. 
2013;50(10):1423-34. 
doi:10.1682/JRRD.2012.08.0135. 
24. Potter B. From Bench to Bedside: A Perfect Fit? 
Osseointegration Can Improve Function for 
Patients with Amputations. Clin Orthop Relat 
Res. 2015:1-3. doi:10.1007/s11999-015-4604-
3. 
25. Schalk S, Jonkergouw N, van der Meer F, Swaan 
WM, Aschoff H-H, van der Wurff P. The 
Evaluation of Daily Life Activities after 
Application of an Osseointegrated Prosthesis 
Fixation in a Bilateral Transfemoral Amputee: 
A Case Study. Medicine. 2015;94(36):e1416. 
doi:10.1097/md.0000000000001416. 
26. van Eck CF, McGough RL. Clinical outcome of 
osseointegrated prostheses for lower extremity 
amputations: a systematic review of the 
 Development of a procedure for the government provision of bone-anchored prosthesis using 
osseointegration in Australia 
2017, PharmacoEconomics Open - http://rdcu.be/s99d2017 Page 10 of 18 
 
literature. Curr Orthop Pract. 2015;26(4):349-
57. doi:10.1097/bco.0000000000000248. 
27. Al Muderis M, Khemka A, Lord S, Van de Meent 
H, Fro lke J. Safety of Osseointegrated 
Implants for Transfemoral Amputees: A Two-
Center Prospective Cohort Study. J Bone Joint 
Surg. 2016;98(11):900-9. 
doi:10.2106/jbjs.15.00808. 
28. Haket LM, Frolke JP, Verdonschot N, 
Tomaszewski PK, van de Meent H. 
Periprosthetic cortical bone remodeling in 
patients with an osseointegrated leg 
prosthesis. J Orthop Res. 2016. 
doi:10.1002/jor.23376. 
29. Tillander J, Hagberg K, Hagberg L, Branemark 
R. Osseointegrated titanium implants for limb 
prostheses attachments: infectious 
complications. Clin Orthop Relat Res. 
2010;468(10):2781-8. doi:10.1007/s11999-
010-1370-0. 
30. Frossard L, Hagberg K, Häggström E, Lee Gow 
D, Brånemark R, Pearcy M. Functional 
Outcome of Transfemoral Amputees Fitted 
With an Osseointegrated Fixation: Temporal 
Gait Characteristics. JPO Journal of 
Prosthetics and Orthotics. 2010;22(1):11-20. 
doi:10.1097/JPO.0b013e3181ccc53d. 
31. Frossard LA, Tranberg R, Haggstrom E, Pearcy 
M, Branemark R. Load on osseointegrated 
fixation of a transfemoral amputee during a 
fall: loading, descent, impact and recovery 
analysis. Prosthet Orthot Int. 2010;34(1):85-
97. doi:10.3109/03093640903585024. 
32. Lee W, Frossard L, Hagberg K, Haggstrom E, 
Lee Gow D, Gray S et al. Magnitude and 
variability of loading on the osseointegrated 
implant of transfemoral amputees during 
walking. Med Eng Phys. 2008;30(7):825-33. 
doi:10.1016/j.medengphy.2007.09.003. 
33. Leijendekkers RA, van Hinte G, Frolke JP, van 
de Meent H, Nijhuis-van der Sanden MW, 
Staal JB. Comparison of bone-anchored 
prostheses and socket prostheses for patients 
with a lower extremity amputation: a 
systematic review. Disabil Rehabil. 2016:1-
14. doi:10.1080/09638288.2016.1186752. 
34. Webster JB, Chou T, Kenly M, English M, 
Roberts TL, Bloebaum RD. Perceptions and 
Acceptance of Osseointegration Among 
Individuals With Lower Limb Amputations: A 
Prospective Survey Study. JPO Journal of 
Prosthetics and Orthotics. 2009;21(4):215-22. 
doi:10.1097/JPO.0b013e3181bfafba. 
35. Haggstrom EE, Hansson E, Hagberg K. 
Comparison of prosthetic costs and service 
between osseointegrated and conventional 
suspended transfemoral prostheses. Prosthet 
Orthot Int. 2013;37(2):152-60. 
doi:10.1177/0309364612454160. 
36. Eckermann S, Sheridan L. Supporting Medicare 
Health, Equity and Efficiency in Australia: 
Policies Undermining Bulk Billing Need to 
Be Scrapped. Appl Health Econ Health 
Policy. 2016;14(5):511-4. 
doi:10.1007/s40258-016-0258-x. 
37. Sorenson C, Drummond M. Improving Medical 
Device Regulation: The United States and 
Europe in Perspective. Milbank Quarterly. 
2014;92(1):114-50. doi:10.1111/1468-
0009.12043. 
38. Briggs AM, Towler SCB, Speerin R, March LM. 
Models of care for musculoskeletal health in 
Australia: now more than ever to drive 
evidence into health policy and practice. 
Australian Health Review. 2014;38(4):401-5.  
39. Dwan KM, McInnes PC. Increasing the influence 
of one’s research on policy. Australian Health 
Review. 2013;37(2):194-8.  
40. Weil AR. The Winding Path To Effective Policy. 
Health Affairs. 2014;33(8):1310. 
doi:10.1377/hlthaff.2014.0799. 
41. Armstrong BK, Gillespie JA, Leeder SR, Rubin 
GL, Russell LM. Challenges in health and 
health care for Australia. The Medical journal 
of Australia. 2007;187(9):485-9.  
42. Geertzen J, van der Linde H, Rosenbrand K, 
Conradi M, Deckers J, Koning J et al. Dutch 
evidence-based guidelines for amputation and 
prosthetics of the lower extremity: 
Rehabilitation process and prosthetics. Part 2. 
Prosthet Orthot Int. 2015;39(5):361-71. 
doi:10.1177/0309364614542725. 
43. Sedki I, Fisher K. Developing prescribing 
guidelines for microprocessor-controlled 
prosthetic knees in the South East England. 
Prosthet Orthot Int. 2015;39(3):250-4. 
doi:10.1177/0309364614525801. 
44. Frossard L. Are bone-anchored prostheses about 
to revolutionise the world of prosthetics?  
Australian Orthotic Prosthetic Association 
(AOPA) Congress; Melbourne, Australia2014. 
45. Frossard L, Formosa D, Quincey T, Berg D, 
Burkett B. Cost effectiveness of 
osseointegration.  2nd Australasian 
Osseointegrated for Amputees Conference; 
Brisbane, Australia2015. p. 3. 
46. Carter D, Vogan A, Haji Ali Afzali H. 
Governments Need Better Guidance to 
Maximise Value for Money: The Case of 
Australia's Pharmaceutical Benefits Advisory 
Committee. Appl Health Econ Health Policy. 
 Development of a procedure for the government provision of bone-anchored prosthesis using 
osseointegration in Australia 
2017, PharmacoEconomics Open - http://rdcu.be/s99d2017 Page 11 of 18 
 
2016;14(4):401-7. doi:10.1007/s40258-015-
0220-3. 
47. Reason P. The SAGE Handbook of Action 
Research. In: Bradbury H, editor. 2nd ed2008. 
48. Muhlbacher AC, Juhnke C. Patient preferences 
versus physicians' judgement: does it make a 
difference in healthcare decision making? 
Appl Health Econ Health Policy. 
2013;11(3):163-80. doi:10.1007/s40258-013-
0023-3. 
49. van Voorn GAK, Vemer P, Hamerlijnck D, 
Ramos IC, Teunissen GJ, Al M et al. The 
Missing Stakeholder Group: Why Patients 
Should be Involved in Health Economic 
Modelling. Applied Health Economics and 
Health Policy. 2016;14(2):129-33. 
doi:10.1007/s40258-015-0200-7. 
50. Frossard L, Berg D, Merlo G, T Q, B B. Cost-
comparison of socket-suspended and bone-
anchored transfemoral prostheses. JPO: 
Journal of Prosthetics and Orthotics. 2017; In 
press.  
51. Proctor EK, Landsverk J, Aarons G, Chambers D, 
Glisson C, Mittman B. Implementation 
research in mental health services: an 
emerging science with conceptual, 
methodological, and training challenges. 
Administration and policy in mental health. 
2009;36(1):24-34. doi:10.1007/s10488-008-
0197-4. 
52. Klein K, Sorra J. The challenge of innovation 
implementation. Academy of management 
review. 1996:1055–80.  
53. Kitson A, Harvey G, McCormack B. Enabling 
the implementation of evidence based 
practice: a conceptual framework. Quality in 
health care : QHC. 1998;7(3):149-58.  
54. Rycroft-Malone J. The PARIHS framework--a 
framework for guiding the implementation of 
evidence-based practice. Journal of nursing 
care quality. 2004;19(4):297-304.  
55. Aarons GA, Hurlburt M, Horwitz SM. Advancing 
a conceptual model of evidence-based practice 
implementation in public service sectors. 
Administration and policy in mental health. 
2011;38(1):4-23. doi:10.1007/s10488-010-
0327-7. 
56. Rubin L, Kennon L, Keggi J, Aschoff H, editors. 
Surgical management  of trans-femoral 
amputation with a  transcutaneous, press-fit 
distal femoral intra-medullary device: analysis 
with minimum 2 year follow-up. Journal of 
Bone and Joint Surgery, British Volume; 2012 
May 1, 2012. 
57. Aschoff H, Kennon R, Keggi J, Rubin L. 
Transcutaneous, distal femoral, intramedullary 
attachment for above-the-knee prostheses: an 
endo-exo device. J Bone Joint Surg Am. 
2010;92 Suppl 2(Supplement 2):180-6. 
doi:10.2106/JBJS.J.00806. 
58. Frossard L, Tranberg R, Haggstrom E, Pearcy M, 
Branemark R. Fall of a transfemoral amputee 
fitted with osseointegrated fixation: loading 
impact on residuum. Gait Posture. 
2009;30(Supplement 2):S151-S2. 
doi:10.1016/j.gaitpost.2009.08.227     
59. Frossard L, Haggstrom E, Hagberg K, Branemark 
P. Load applied on a bone-anchored 
transfemoral prosthesis: characterisation of 
prosthetic components – A case study J 
Rehabil Res Dev. 2013;50(5):619–34. 
doi:10.1682/JRRD.2012.04.0062. 
60. Frossard LA. Load on osseointegrated fixation of 
a transfemoral amputee during a fall: 
Determination of the time and duration of 
descent. Prosthet Orthot Int. 2010;34(4):472-
87. doi:10.3109/03093646.2010.520057. 
61. Highsmith MJ, Kahle JT, Bongiorni DR, Sutton 
BS, Groer S, Kaufman KR. Safety, energy 
efficiency, and cost efficacy of the C-Leg for 
transfemoral amputees: A review of the 
literature. Prosthet Orthot Int. 2010;34(4):362-
77. doi:10.3109/03093646.2010.520054. 
62. Ash S, O'Connor J, Anderson S, Ridgewell E, 
Clarke L. A mixed-methods research 
approach to the review of competency 
standards for orthotist/prosthetists in 
Australia. Int J Evid Based Healthc. 
2015;13(2):93-103. 
doi:10.1097/XEB.0000000000000038. 
63. Vertriest S, Coorevits P, Hagberg K, Branemark 
R, Haggstrom E, Vanderstraeten G et al. 
Static load bearing exercises of individuals 
with transfemoral amputation fitted with an 
osseointegrated implant: reliability of kinetic 
data. IEEE Trans Neural Syst Rehabil Eng. 
2015;23(3):423-30. 
doi:10.1109/TNSRE.2014.2337956. 
64. Al Muderis M, Tetsworth K, Khemka A, Wilmot 
S, Bosley B, Lord SJ et al. The 
Osseointegration Group of Australia 
Accelerated Protocol (OGAAP-1) for two-
stage osseointegrated reconstruction of 
amputated limbs. Bone & Joint Journal. 
2016;98-B(7):952-60. doi:10.1302/0301-
620x.98b7.37547. 
65. Vertriest S, Coorevits P, Hagberg K, Branemark 
R, Haggstrom EE, Vanderstraeten G et al. 
Static load bearing exercises of individuals 
with transfemoral amputation fitted with an 
osseointegrated implant: Loading compliance. 
 Development of a procedure for the government provision of bone-anchored prosthesis using 
osseointegration in Australia 
2017, PharmacoEconomics Open - http://rdcu.be/s99d2017 Page 12 of 18 
 
Prosthet Orthot Int. 2017;In press. 
doi:10.1177/0309364616640949. 
66. Frossard L, Hagberg K, Haggstrom E, Branemark 
R. Load-relief of walking aids on 
osseointegrated fixation: instrument for 
evidence-based practice. IEEE Trans Neural 
Syst Rehabil Eng. 2009;17(1):9-14. 
doi:10.1109/TNSRE.2008.2010478. 
67. Frossard L, Gow DL, Hagberg K, Cairns N, 
Contoyannis B, Gray S et al. Apparatus for 
monitoring load bearing rehabilitation 
exercises of a transfemoral amputee fitted 
with an osseointegrated fixation: a proof-of-
concept study. Gait Posture. 2010;31(2):223-
8. doi:10.1016/j.gaitpost.2009.10.010. 
68. Okike K, O’Toole RV, Pollak AN, Bishop JA, 
McAndrew CM, Mehta S et al. Survey Finds 
Few Orthopedic Surgeons Know The Costs 
Of The Devices They Implant. Health Affairs. 
2014;33(1):103-9. 
doi:10.1377/hlthaff.2013.0453. 
69. Geil MD. JPO Editor’s Comments. Journal of 
Prosthetics and Orthotics: JPO. 
2016;28(3):93.  
70. Pitkin M, Cassidy C, Muppavarapu R, J R, 
Shevtsov M, Galibin O et al. New method of 
fixation of in-bone implanted prosthesis. J 
Rehabil Res Dev. 2013;50(5):709-22. 
doi:10.1682/JRRD.2012.11.0202. 
71. Tomaszewski PK, Verdonschot N, Bulstra SK, 
Verkerke GJ. A New Osseointegrated 
Fixation Implant for Amputated Patients. J 
Biomech. 2012;45(0):S322. 
doi:10.1016/s0021-9290(12)70323-8. 
72. Guirao L, Samitier CB, Costea M, Camos JM, 
Majo M, Pleguezuelos E. Improvement in 
walking abilities in transfemoral amputees 
with a distal weight bearing implant. Prosthet 
Orthot Int. 2017;41(1):26-32. 
doi:10.1177/0309364616633920. 
73. Kang NV, Pendegrass C, Marks L, Blunn G. 
Osseocutaneous integration of an intraosseous 
transcutaneous amputation prosthesis implant 
used for reconstruction of a transhumeral 
amputee: Case report. The Journal of Hand 
Surgery. 2010;35(7):1130-4.  
74. Sorenson C, Drummond M, Burns LR. Evolving 
Reimbursement And Pricing Policies For 
Devices In Europe And The United States 
Should Encourage Greater Value. Health 
Affairs. 2013;32(4):788-96. 
doi:10.1377/hlthaff.2012.1210. 
75. Hagberg K, Branemark R, Hagg O. Questionnaire 
for Persons with a Transfemoral Amputation 
(Q-TFA): initial validity and reliability of a 
new outcome measure. J Rehabil Res Dev. 
2004;41(5):695-706.  
76. Deans SA, McFadyen AK, Rowe PJ. Physical 
activity and quality of life: A study of a lower-
limb amputee population. Prosthet Orthot Int. 
2008;32(2):186-200. 
doi:10.1080/03093640802016514. 
77. Samuelsson KA, Toytari O, Salminen AL, Brandt 
A. Effects of lower limb prosthesis on 
activity, participation, and quality of life: a 
systematic review. Prosthet Orthot Int. 
2012;36(2):145-58. 
doi:10.1177/0309364611432794. 
78. Briggs A, Sculpher M, Dawson J, Fitzpatrick R, 
Murray D, Malchau H. The use of 
probabilistic decision models in technology 
assessment : the case of total hip replacement. 
Appl Health Econ Health Policy. 
2004;3(2):79-89.  
79. Voigt J, Mosier M. Is more expensive medical 
technology better? The use of analytics in the 
evaluation of clinical outcomes for different 
material compositions of total knee implants. 
Appl Health Econ Health Policy. 
2012;10(5):289-93. doi:10.2165/11630670-
000000000-00000. 
80. Ijzerman MJ, Steuten LM. Early assessment of 
medical technologies to inform product 
development and market access: a review of 
methods and applications. Appl Health Econ 
Health Policy. 2011;9(5):331-47. 
doi:10.2165/11593380-000000000-00000. 
 
 
 
 
 
 
 
 Development of a procedure for the government provision of bone-anchored prosthesis using osseointegration in Australia 
2017, PharmacoEconomics Open - http://rdcu.be/s99d2017 Page 13 of 18 
 
Table 1. Contextual information about the study setting (QALS: Queensland Artificial Limb Service, BAP: Bone-anchored prosthesis, TFA: Individuals with transfemoral 
amputation, PSP: Prosthetic Service Provider).  
Descriptor Information 
Geographical information about State of Queensland 
Capital city  Brisbane 
Population  4,7 million 
Size  1,8 million km² 
Average temperature  Summer: 35C - 21C, Winter: 22C - 10C  
Average humidity  Summer: 50%, Winter: 65% - 75%, 
Description of QALS 
Location  Brisbane 
State organisation 
 Relates to the Medical Aids Subsidy Scheme, Metro South Health and ultimately the 
Queensland Government Minister of Health 
Role 
 Provide prosthetic services (e.g., artificial limbs) to eligible residents of Queensland, under 
the State Government’s ‘Artificial Limb Scheme’ 
Yearly budget  $5.4M 
Number of consumers registered  Over 7,000 
Number of active consumers per year  Over 3,000 
Number of active consumers with TFA  Over 600 (20%) 
Number of PSPs  6 to 10 
Drives to develop procedure 
Demand from consumers  QALS could face requests from up to 550 consumers to be fitted with BAP 
Benefits of BAP  Countless anecdotal accounts of BAP clinical benefits in grey and professional reports  
 Preliminary scientific evidence demonstrating clinical benefits of BAP  
Economic incentives  Possible cost-effectiveness of BAP compared to socket prosthesis 
 upcoming consumers could cost tax payers over $60M in the next 12 years 
Managerial decision  Aspiration to be a key player in development of procedure worldwide 
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Table 2. Cost breakdown of Prosthetic Service Provider (PSP) labour ($150 per hour) included in the schedule of allowable fixed expenses in QALS’ procedure to provide 
prosthetic services and components to consumers fitted with bone-anchored prostheses. 
Treatment stage Procedure phase 
Items 
Timeline 
Cost 
ID Intervention PSP Labour 
        (Mth) (Hrs) ($) 
Pre-op P1 P1-A Screening consultation -3.0 2.0  $     300  
Pre-op P1 P1-B Creation of passport -2.0 0.5  $       75  
Surgery P2 P2-A Consultation after surgeries 0.5 2.0  $     300  
Surgery P2 P2-B Completion of passport 1.0 0.5  $       75  
Rehab P3 P3-A Pre-fitting of light limb 1.5 1.0  $     150  
Rehab P3 P3-B Fitting of light limb 2.0 4.0  $     600  
Rehab P3 P3-C Completion of passport 2.5 0.5  $       75  
Rehab P4 P4-A Pre-fitting of definitive limb 3.0 1.0  $     150  
Rehab P4 P4-B Fitting of definitive limb 3.5 10.0  $   1,500  
Rehab P4 P4-C Completion of passport 4.0 0.5  $       75  
      Total fixed   22.0  $ 3,300  
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Table 3. Overview initial and ongoing obstacles identified after implementation of formal procedure for provision of bone-anchored prostheses (PSP: Prosthetic Service 
Provider). 
  Governmental control 
 
Within Outside 
Initial Obstacles     
• Estimation of PSPs hours for pre-op, surgery and post-op prosthetic care x 
 • Review of QALS paradigm for allocation of advanced knee unit  x 
 • Absence of procedures for pre-op, surgery and post-op care x 
 • Difficulties to extract easily individuals and overall costs for BAP consumers x 
 • Dealing with treatment occurring interstate and possibly overseas x 
 • Lack of definitive rehabilitation guideline for press-fit fixation 
 
x 
• Lack of guidelines for BAP prosthetic care (e.g., choice of knee unit)  
 
x 
• Limited scientific evidence about clinical harms for press-fit fixation   
 
x 
• Limited funding to perform action research 
 
x 
Ongoing Obstacles     
• Reduction of the number of processes before Phase 5 of the procedure   x 
 • Funding for ongoing monitoring of procedure (e.g., cost, satisfaction) x 
 • Slight broadening of PSPs role (e.g., case management) 
 
x 
• Standardisation of passport of service (e.g., creation of electronic version) 
 
x 
• Continual  evolutions of surgical procedures (e.g., single stage) 
 
x 
• Constant developments of conventional prosthetic components  
 
x 
• Unpredictable developments of specific components for BAP (e.g., connector)  x 
• Change of national framing policy (e.g., National Disability Insurance Scheme)   x 
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Table 4. Overview of known and suggested facilitators to implementation identified after implementation of formal procedure for provision of bone-anchored prostheses 
(PSP: Prosthetic Service Provider, AMPAT: Amputee Mobility Predictor Assessment Tool; FDA: Food and Drug Administration, SF36: Short From 36, Q-TFA: 
Questionnaire for Transfemoral amputees). 
  Governmental control 
  Within Outside 
Known Facilitators     
• Engage early with stakeholders, particularly PSPs x 
 • Adapt existing processes rather than creating ones  x 
 • Create of passport of service (e.g., interstate care) x 
 • Assess  actual prosthetic needs from PSPs and consumer’s perspectives  x 
 • Clarify PSPs role and responsibilities (e.g., case manager) x 
 • Use of standard instruments to assess needs and outcomes (e.g., AMPAT) x 
 • Create database to monitor individual and overall costs x 
 • Negotiate regularly with suppliers of components  x 
 • Will from QALS’ management team to facilitate changes x 
 • Understand rehabilitation and safety requirements  
 
x 
Suggested Facilitators     
• Approve reimbursement before most expensive items  x 
 • Analysis of quarterly reports for progress, compliance, cost and satisfaction x 
 • Use of standard instruments to assess outcomes (e.g., SF36, Q-TFA) x 
 • Educate PSPs about ways to limit cost (e.g., re-use of components) x 
 • Monitor national and international developments (e.g., FDA approval) x 
 • Set processes to assess benefits of treatment (e.g., daily steps count) x 
 • Engage continuously with local clinical teams (e.g., specifics of rehabilitation) x 
 • Engage continuously with suppliers and manufacturers of components  x 
 • Increase funding for action research to develop procedure   x 
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Figure 1. Action-Research process outlining of the timeline and actions for each of the typical steps used to 
develop the formal procedure for provision of bone-anchored prosthesis (BAP). (PSP: Prosthetic Service 
Provider, CPC: Clinical Prosthetic Clearance, APN: Assessment of Prosthetic Need, PID: Prosthetic Issue 
Document) 
 
Figure 2. Overview of intersections between the stages of the bone-anchored prosthesis (BAP) treatment and the 
task, specicalist, document and action in each process during five phases (P1, P2, P3, P4 and P5) of the 
procedure. PSP: Prosthetic Service Provider, Ortho: Orthopaedic specialist, CPC: Clinical Prosthetic Clearance, 
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APN: Assessment of Prosthetic Need, Rehab: Rehabilitation specialist, AMPAT: Amputee Mobility Predictor 
Assessment Tool, PID: Prosthetic Issue Document)  
 
 
